These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships. Song DQ, Wang Y, Wu LZ, Yang P, Wang YM, Gao LM, Li Y, Qu JR, Wang YH, Li YH, Du NN, Han YX, Zhang ZP, Jiang JD. J Med Chem; 2008 Jun 12; 51(11):3094-103. PubMed ID: 18457382 [Abstract] [Full Text] [Related]
25. Synthesis of 1-substituted 3-pyridinylmethylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells. Hung CY, Hsu MH, Huang LJ, Hwang CS, Lee O, Wu CY, Chen CH, Kuo SC. Bioorg Med Chem; 2008 Apr 15; 16(8):4222-32. PubMed ID: 18346898 [Abstract] [Full Text] [Related]
26. Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents. Vogel S, Kaufmann D, Pojarová M, Müller C, Pfaller T, Kühne S, Bednarski PJ, von Angerer E. Bioorg Med Chem; 2008 Jun 15; 16(12):6436-47. PubMed ID: 18513974 [Abstract] [Full Text] [Related]
27. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents. Gallet S, Flouquet N, Carato P, Pfeiffer B, Renard P, Léonce S, Pierré A, Berthelot P, Lebegue N. Bioorg Med Chem; 2009 Feb 01; 17(3):1132-8. PubMed ID: 19162484 [Abstract] [Full Text] [Related]
28. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. Ghorab MM, Ragab FA, Heiba HI, Arafa RK, El-Hossary EM. Eur J Med Chem; 2010 Sep 01; 45(9):3677-84. PubMed ID: 20684857 [Abstract] [Full Text] [Related]
29. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives. Loza-Mejía MA, Olvera-Vázquez S, Maldonado-Hernández K, Guadarrama-Salgado T, González-Sánchez I, Rodríguez-Hernández F, Solano JD, Rodríguez-Sotres R, Lira-Rocha A. Bioorg Med Chem; 2009 May 01; 17(9):3266-77. PubMed ID: 19364657 [Abstract] [Full Text] [Related]
30. Synthesis and cytotoxicity of new potential intercalators based on tricyclic systems of some pyrimido[5,4-c]cinnoline and pyrimido[5,4-c]quinoline derivatives. Part I. Lewgowd W, Stańczak A, Ochocki Z, Krajewska U, Rózalski M. Acta Pol Pharm; 2005 May 01; 62(2):105-10. PubMed ID: 16161350 [Abstract] [Full Text] [Related]
31. Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity. Zheng J, Deng L, Chen M, Xiao X, Xiao S, Guo C, Xiao G, Bai L, Ye W, Zhang D, Chen H. Eur J Med Chem; 2013 Jul 01; 65():158-67. PubMed ID: 23708010 [Abstract] [Full Text] [Related]
32. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Morley KL, Ferguson PJ, Koropatnick J. Cancer Lett; 2007 Jun 18; 251(1):168-78. PubMed ID: 17197076 [Abstract] [Full Text] [Related]
33. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY. Lung Cancer; 2008 Feb 18; 59(2):180-91. PubMed ID: 17900752 [Abstract] [Full Text] [Related]
34. Phenylcinnamides as novel antimitotic agents. Leslie BJ, Holaday CR, Nguyen T, Hergenrother PJ. J Med Chem; 2010 May 27; 53(10):3964-72. PubMed ID: 20411988 [Abstract] [Full Text] [Related]
35. Design, regioselective synthesis and cytotoxic evaluation of 2-aminoimidazole-quinoline hybrids against cancer and primary endothelial cells. Singh K, Verma V, Yadav K, Sreekanth V, Kumar D, Bajaj A, Kumar V. Eur J Med Chem; 2014 Nov 24; 87():150-8. PubMed ID: 25247771 [Abstract] [Full Text] [Related]
37. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives. Teng CH, Won SJ, Lin CN. Bioorg Med Chem; 2005 May 16; 13(10):3439-45. PubMed ID: 15848756 [Abstract] [Full Text] [Related]